A detailed history of Atria Investments LLC transactions in Xencor Inc stock. As of the latest transaction made, Atria Investments LLC holds 14,835 shares of XNCR stock, worth $342,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,835
Previous 14,611 1.53%
Holding current value
$342,243
Previous $276,000 7.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$15.7 - $21.65 $3,516 - $4,849
224 Added 1.53%
14,835 $298,000
Q2 2024

Aug 13, 2024

BUY
$18.21 - $24.5 $266,066 - $357,969
14,611 New
14,611 $276,000
Q2 2019

Aug 09, 2019

BUY
$29.6 - $40.93 $311,362 - $430,542
10,519 New
10,519 $0

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.